Ianalumab, an ADCC-Enhanced Anti-BAFF-Receptor Antibody, Has Beneficial Effects in an Active Mouse Model of Immune Thrombocytopenia (ITP)

Oral Presentation
© 2024 American Society of Hematology. All rights reserved.
Meeting: 2024 ASH® Annual Meeting
Indication: Immune Thrombocytopenia (ITP)
Presenter: John W Semple, PhD
Affiliation: Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden; Clinical Immunology and Transfusion Medicine, Office of Medical Services, Lund, Sweden
Presentation Date: December 8, 2024
Abstract Number: 552
Session: Session: 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Big Data and Basic Science
Related content: Immune Thrombocytopenia (ITP)
Oral Presentation
Abstract Number: 710
Presenter: David J Kuter, MD, DPhil
Indication: Immune Thrombocytopenia (ITP)
Date Presented: December 9, 2024

To access this content please accept the following declarations.

This content was selected by and is provided to you upon your unsolicited request courtesy of Novartis with permission of ASH®.